Trends in seroprevalence of hepatitis B, hepatitis C, HIV, and syphilis infections in Iranian blood donors from 2003 to 2005

Hepatitis Monthly

Volumn 9, Issue 1, 2009, Pages 24-28

  Khedmat, Hossein ^a   Alavian, Seyed Moayed ^a   Miri, Seyyed Mohammad ^a   Amini, Mohsen ^a   Abolghasemi, Hassan ^b   Hajibeigi, Bashir ^b   Alaeddini, Farshid ^a   Fallahian, Farahnaz ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

Author keywords

Hepatitis B; Hepatitis C; HIV; Seroprevalence; Syphilis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CROSS-SECTIONAL STUDY; DONOR SELECTION; ENZYME IMMUNOASSAY; FLUORESCENT TREPONEMA ANTIBODY TEST; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREACTIVITY; IRAN; RISK REDUCTION; SENSITIVITY ANALYSIS; SEROPREVALENCE; SYPHILIS; TREND STUDY; WESTERN BLOTTING;

EID: 67649342221     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Haenszel W, Loveland DB, Sirken MG. Lung-cancer mortality as related to residence and smoking histories. I. White males. J Natl Cancer Inst. 1962;28:947-1001.
2. Donahue JG, Munoz A, Ness PM, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992;327(6):369-73.
3. Alter MJ. The epidemiology of acute and chronic hepatitis C. Clin Liver Dis. 1997;1(3):559-68, vi-vii.
4. Yildirim B, Tahan V, Ozaras R, et al. Hepatitis C virus risk factors in the Turkish community. Dig Dis Sci. 2005; 50(12):2352-5.
5. Vera de Leon L, Juarez Navarro JA, Diaz Gomez M, et al. [Epidemiologic and situational panorama of hepatitis C in Mexico]. Rev Gastroenterol Mex. 2005;70(1):25-32.
6. Goritsas C, Plerou I, Agaliotis S, et al. HCV infection in the general population of a Greek island: prevalence and risk factors. Hepatogastroenterology. 2000;47(33):782-5.
7. Grant WC, Jhaveri RR, McHutchison JG, Schulman KA, Kauf TL. Trends in health care resource use for hepatitis C virus infection in the United States. Hepatology. 2005;42(6):1406-13.
8. Seyfried H, Brojer E, Grabarczyk P, Rosinska M, Gronowska A, Letowska M. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003]. Przegl Epidemiol. 2005;59(4):807-14.
9. Akhtar S, Younus M, Adil S, Jafri SH, Hassan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat. 2004;11(6):527-35.
10. McLindon JP, Paver WK, Babbs C, et al. Hepatitis C-related chronic liver disease among asymptomatic blood donors in the north west of England. J Infect. 1995;30(3):253-9.
11. Niederhauser C, Schneider P, Fopp M, Ruefer A, Levy G. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003. Euro Surveill. 2005; 10(2):14-6.
12. Akbar N, Basuki B, Mulyanto, Garabrant DH, Sulaiman A, Noer HM. Ethnicity, socioeconomic status, transfusions and risk of hepatitis B and hepatitis C infection. J Gastroenterol Hepatol. 1997; 12(11):752-7.
13. Ruff TA, Gertig DM, Otto BF, et al. Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia. J Infect Dis. 1995;171(2):290-6.
14. Marshall IB. Screening and vaccination for hepatitis B in Hong Kong University students. J Am Coll Health. 1995;44(2):59-62.
15. Singh B, Kataria SP, Gupta R. Infectious markers in blood donors of East Delhi: prevalence and trends. Indian J Pathol Microbiol. 2004; 47(4):477-9.
16. Nantachit N, Robison V, Wongthanee A, Kamtorn N, Suriyanon V, Nelson KE. Temporal trends in the prevalence of HIV and other transfusion-transmissible infections among blood donors in northern Thailand, 1990 through 2001. Transfusion. 2003;43(6):730-5.
17. Lu L, Jia MH, Zhang XB, et al. [Analysis for epidemic trend of acquired immunodeficiency syndrome in Yunnan Province of China]. Zhonghua Yu Fang Yi Xue Za Zhi. 2004;38(5):309-12.
18. Nikolopoulos G, Arvanitis M, Masgala A, Paraskeva D. Migration and HIV epidemic in Greece. Eur J Public Health. 2005;15(3):296-9.
19. Mood B, Keykhah F, Moghadam E, et al. Prevalence of Hepatitis B Surface Antigen in Pregnant Women in Zahedan, Iran. Hep Mon. 2004;4(8):161-3.
20. Alavian SM. Ministry of Health in Iran Is Serious about Controlling Hepatitis B. Hep Mon. 2007;7(1):3-5.